All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
The patient had been battling DFSP for over eight years, enduring multiple recurrences despite three previous surgeries
Projects 5X revenue growth by 2028, accelerates global market leadership and paves the way for IPO
The projected business potential is around US$ 1 million in the first year
The technology offers scalable continuous granulation at 200 kg/hour, with the potential to exceed 500 kg/hour for certain granules
Alkem’s domestic business grew 9.7 per cent versus the Indian pharmaceutical market growth of 8.5 per cent
The company’s acquisition of a 51 per cent stake in Saarathi Healthcare earlier this financial year boosted growth
The new facility will enhance AbbVie’s chemical synthesis capacity to support domestic production of current and next-generation neuroscience, immunology, and oncology medicines
EBITDA stood at Rs. 100.1 crore with a margin of 16.1 per cent
Subscribe To Our Newsletter & Stay Updated
